CALC
Calcimedica Inc
NASDAQ · Pharmaceuticals
$0.60
-0.01 (-1.77%)
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.85M | 1.83M | 1.75M |
| Net Income | 558.6K | 478.0K | 437.1K |
| EPS | — | — | — |
| Profit Margin | 30.2% | 26.2% | 25.0% |
| Rev Growth | +1.8% | +20.8% | +4.5% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 637.1K | 652.6K | 832.4K |
| Total Equity | 5.71M | 6.19M | 5.86M |
| D/E Ratio | 0.11 | 0.11 | 0.14 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | 671.1K | 736.1K | 607.5K |
| Free Cash Flow | 473.4K | 406.9K | 399.5K |